How Dallara was paid
$8.4M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Que DallaraChief Executive Officer | $810,769 | $965,000 | $3,347,506 | $3,218,844 | $88,109 | $8,430,228 |
| Chad SpoonerExecutive Vice President, Chief Financial Officer | $519,231 | $970,000 | $4,885,460 | $647,908 | $43,994 | $7,066,593 |
| Ali DianatyExecutive Vice President, Chief Product & Technology Officer | $591,440 | $907,385 | $1,313,020 | $959,352 | $66,140 | $3,837,337 |
| Courtney Nelson WillsSenior Vice President, General Counsel | $462,673 | $330,000 | $321,596 | $593,456 | $57,513 | $1,765,238 |
| Gillian ChandrasenaSenior Vice President, Chief Human Resources Officer | $449,731 | $835,000 | $796,349 | $492,182 | $32,560 | $2,605,822 |
What changed and why
- $8.4M$8,430,228 was CEO Que Dallara’s 2026 total compensation, compared with $8,458,163 in 2025.
- $1.5M2026 IPO awards included $1,500,000 of target performance-based restricted stock units for Dallara.
- $1.5M$1,500,000 was the stated value of Dallara’s 2026 nonqualified stock option award.
- $500K$500,000 of Spooner’s one-time new-hire cash bonus was included in 2026 compensation.
- $32.05$32.05 per share was the target closing price required for the 2026 IPO performance-based restricted stock units.
- 2026 bonus amounts included Medtronic incentive-plan payments and were subject to mid-year calibrations.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.